Human beings are known for having many unique tendencies, and a prominent one from that pack is our tendency to looking for better solutions under all circumstances. This allows us to maintain a progressive stance over the course of our lives, therefore keeping constant progression well within the reach. Now, while such an instinct is important, what’s even more critical is how we implement it from an actionable standpoint. In fact, the significance held by the latter factor is reflected quite clearly in every single method we have used to solve a given question. However, despite the expansiveness in play here, no method, so far, has managed to validate the said significance like technology does on a consistent basis. You see, technology didn’t just introduce some entirely new ideas. Instead, it also guided us at length about using them in the most efficient way possible. Such a dynamic has been on show since day one of technology’s journey, except its most notable moment came when the creation decided to make a bold foray into the medical sector. We call it most notable because after this foray, our medical sector was never the same. The healthcare ideology was suddenly revolving entirely around patient’s needs, something that wasn’t really the case earlier. The revolution is still in full swing, and that was proved yet again by a recent collaboration between Komodo Health and Rare as One.
Komodo Health has officially announced a partnership with Chan Zuckerberg’s initiative called Rare as One, as the two organizations try to find a way beyond certain rare diseases. According to few relevant reports, the partnership will see 50 companies under the initiative’s umbrella using Komodo’s Healthcare Map Technology, which is basically designed to bolster early diagnoses, scale up research quality, and consequentially, make core healthcare setup more complete. If numbers touted by Komodo Health are to be believed, then the company’s Map technology currently boasts a repository of de-identified data from over 330 million patients. The said data delivers in-depth information on various integral factors like demographics, disease stage, and geographical details etc. It’s a big deal because, up until now, tracking and analyzing patients with rare diseases hasn’t been an easy job, hence a system like that could very well pull off a major alternation in the healthcare sector’s trajectory.
“We are excited to support the Rare As One Network organizations as they utilize Komodo’s software to address unanswered questions in their disease areas,” said Heidi Bjornson-Pennell, Rare As One Program Manager. “We believe in the power of data and technology to unearth the critical insights needed to address the unmet needs of these patient communities.”
